Trial NCT04131517

View at ClinicalTrials.gov 
Org. Study IDs: UP0035
Secondary IDs: 2019-002194-54

Last trial update was posted on 2021-06-24

MeSH Interventions

Ethinyl Estradiol-Norgestrel Combination Ethinyl estradiol, levonorgestrel drug combination Padsevonil

MeSH Conditions


Other Conditions

Healthy Female Participants

Stopping Reasons

Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures

Limitations And Caveats

The study was terminated on 22 May 2020 because the program developing padsevonil in focal-onset seizures was stopped.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID